to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Medical device startups and other new healthcare businesses can benefit from StartUp Health, a strategic initiative to connect entrepreneurs with resources.
Health IT, innovation and business models are some of the topics addressed in this Q&A session with Richard Foster, a new partner at venture capital firm Lux Capital. Read more for his views on the future of health IT and his advice for new entrepreneurs.
Life science startups looking for funding should keep foundations in mind as a potential source. Read more for tips on getting funding from foundations.
If you guessed that the top life sciences markets are on the east and west coasts, you'd be right. However, several parts of the Midwest are now considered emerging markets. Read more to learn the locations of the top 10 life sciences markets.
Medical device startups will be way ahead of their competitors if they know what to expect from the FDA approval process. Read more for tips on how to be prepared.
Federal regulations and overseas competition are just two of the barriers holding back medical device innovation, says one medical device industry executive. Read more about the other roadblocks to innovation.
It’s all part of the evolution of pharmaceutical marketing. The old way of pharmaceutical reps stopping by doctors’ offices during the business day won’t cut it in modern marketing. Read about how one pharmaceutical business is planning to change the way their salesforce operates. “(Doctors,) frankly, don’t have time and they particularly don’t have time during the day, which is exactly when reps are showing up,” says Pozen's Liz Cermak.
Former U.S. Senator Tom Daschle gives his viewpoint on healthcare reform legislation and the obstacles ahead. Read more to learn about the legal, administrative and regulatory challenges ahead as a result of this major legislation.
A new biomedical endowment at Duke University will support a program that has already launched new healthcare businesses. Read more to find out about Duke’s successes in commercializing medical technology.
The venture capital climate improved in RTP in the first quarter, but biotech companies are still competing for dollars. Several RTP companies saw venture capital investment for development of pharmaceutical products and medical technologies. Read more to learn about the venture capital climate.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.